SCHEMBL4024232

SCHEMBL4024232

O=C(c1ccc2c(ccc3occc32)c1)c1c[nH]cn1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 4/20 0.33
WNT3A P56704 4/20 0.33
HTR1B P28222 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
NFKB1 P19838 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
HPGD P15428 1/20 0.31
NAMPT P43490 1/20 0.31
HIPK2 Q9H2X6 2/20 0.31
KMO O15229 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
WNT1 P04628 1/20 0.31
DYRK1A Q13627 1/20 0.31
KDM4E B2RXH2 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5750943 0.74 MEN1 (0.51) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL4030413 0.73 NPC1 (0.32) CTNNB1MAPTPOLBRAB9AIGFBP3
SCHEMBL5752322 0.71 L3MBTL1 (0.41) ALDH1A1LMNARAB9AL3MBTL1IGFBP3
SCHEMBL4034041 0.71 NPC1 (0.36) CTNNB1WNT3AALDH1A1MAPTHPGD
SCHEMBL4031880 0.71 CTNNB1 (0.34) CTNNB1WNT3AALDH1A1MAPTHPGD
SCHEMBL5678286 0.70 KDM4E (0.53) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL5678124 0.69 CYP1A2 (0.44) ALDH1A1MAPTKDM4ELMNAL3MBTL1
SCHEMBL5753752 0.69 L3MBTL1 (0.39) ALDH1A1KDM4ELMNAL3MBTL1IGFBP3
SCHEMBL11049942 0.67 SMN1; SMN2 (0.49) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL4028482 0.67 CYP17A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed